Regulatory Matters · 19 November 2026
From device idea to CE mark: the ten steps to the EU market
- The ten steps from device idea to CE mark in the EU, in the order the law sets, with the law behind each one.
- Five mistakes that cost founders months, and how to avoid them.
- If your device was on the EU market before 28 May 2026, its EUDAMED records are due on 28 November, a Saturday, so finish by Friday 27 November. Legacy devices are included.
- The European Parliament's first vote on the MDR revision is now forecast for 18 January 2027, and no committee has voted yet.
- Also inside: four FDA cases and seven dates to watch.
By Daren Wilson, Chief Operating Officer · Regulatory statements reviewed by Niko Mangold
- Published
- 19 November 2026
- Covering
- 9 to 17 November 2026
- Next issue
- 3 December 2026

At a glance
Ten steps to a CE mark, and EUDAMED is due in nine days
| Date | What it means |
|---|---|
| 27 Nov | Finish EUDAMED registration of devices on the market before 28 May 2026; the deadline, 28 November, is a Saturday |
| 30 Nov | Comments close on the US Food and Drug Administration's (FDA) proposed guidance lists |
| 31 Dec | swissdamed registration transition ends in Switzerland |
| 18 Jan | Forecast: Parliament's first vote on the MDR revision, now in 2027 |
Sources: HPRA, FDA, European Parliament Legislative Observatory, Swissmedic. Checked 19 November 2026.
From device idea to CE mark
From device idea to CE mark: the ten steps to the EU market
What the MDR asks of a device sold in the EU, in ten steps, with the law behind each. The order matters: register in EUDAMED before you apply to a Notified Body.
- Confirm your product is a medical device. The law defines a medical device by what its manufacturer intends it to be used for, which includes diagnosis, prevention, and monitoring. You write a short, reasoned decision. MDR Art. 2(1)
- Write the intended purpose. The intended purpose is the use set by your label, your instructions, and your promotional or sales materials. Your technical documentation must open with a description that includes it. You produce one controlled statement. MDR Art. 2(12); Annex II, section 1.1
- Classify the device. Annex VIII sorts devices into classes by rule. Under Rule 11, software that informs diagnosis or treatment decisions is class IIa or higher. MDCG 2019-11 rev.1 explains how to apply it, including to apps wherever they run. You produce a written classification rationale. MDR Annex VIII; MDCG 2019-11 rev.1
- Choose how you will show conformity. The route depends on the class. A class I manufacturer declares conformity itself after drawing up the technical documentation, and a Notified Body takes part only for sterile, measuring, or reusable surgical aspects. From class IIa upwards, you follow one of the procedures in Annexes IX to XI with a Notified Body. You produce a route decision. MDR Art. 52; Annexes IX to XI
- Set up your quality management system and name your PRRC. You must keep a quality management system proportionate to the risk class and type of device, and have at least one person responsible for regulatory compliance; a small company may have one permanently and continuously at its disposal. If you are not established in the EU, you must also designate a sole authorised representative. MDR Art. 10(9), 11, and 15
- Plan and build the clinical evidence. You must plan, conduct, and document a clinical evaluation under Article 61 and Part A of Annex XIV. You produce a clinical evaluation plan and report. MDR Art. 61; Annex XIV
- Compile the technical documentation. Annex II sets what the file contains, including how the device meets the general safety and performance requirements in Annex I, your risk management, and your labelling and instructions for use. Annex III covers post-market surveillance. MDR Annexes I, II, and III
- Register as a manufacturer in EUDAMED. Where a Notified Body takes part, you register in EUDAMED, which gives you a single registration number (SRN), before you apply to it. For class III and class IIb implantable devices, you also assign the Basic UDI-DI before you apply. Every device needs a Basic UDI-DI before it is placed on the market. MDR Art. 29 and 31
- Go through a Notified Body, where your class requires it. You may apply to a Notified Body of your choice, but not to two in parallel for the same procedure, and you must declare any earlier application that was refused or withdrawn. If the assessment succeeds, you receive a certificate. MDR Art. 52 and 53
- Sign the declaration, affix the CE mark, and monitor the device. The EU declaration of conformity states that the requirements are fulfilled, and by drawing it up you take responsibility for compliance. The CE mark goes on before the device is placed on the market, with the Notified Body's number where one took part. Your post-market surveillance system is part of your quality management system, and from class IIa you also produce a periodic safety update report. MDR Art. 19, 20, and 83 to 86
Sources: Regulation (EU) 2017/745, consolidated text of 19 July 2026 on EUR-Lex, and MDCG 2019-11 rev.1, June 2025. Checked 19 November 2026.
Next step. Start with the free MedTech Compass, about ten minutes (AI-generated, not validated). For a written classification rationale and your regulatory pathway, see Pathway Ready.
What to avoid: five mistakes that cost founders months
Five mistakes that cost founders months, and how to avoid each one
These five come from Venitara's experience with founders, so they are our findings and no regulator has made them. Each fix rests on the MDR.
1. Writing the intended purpose last. Your website and sales materials count towards it. Write it first, and check every claim you publish against it. MDR Art. 2(12)
2. Classifying software too low. Software that informs diagnosis or treatment decisions starts at class IIa under Rule 11. Write the classification rationale before you plan the route. MDR Annex VIII
3. Assuming class I means no paperwork. A class I manufacturer still draws up the technical documentation and issues the EU declaration of conformity. Check whether sterility, a measuring function, or reuse brings in a Notified Body. MDR Art. 52(7)
4. Applying to two Notified Bodies at once. The MDR does not allow parallel applications for the same procedure, and you must declare any refused or withdrawn earlier application. Choose one body, and keep a record of every earlier contact. MDR Art. 53
5. Leaving the quality system and your PRRC until the end. The MDR requires both, and the system must fit your class and device type. Name the PRRC early, and use the small-company option if it applies. MDR Art. 10(9) and 15
Next step. Unsure which of these applies to your device? Talk to a regulatory expert.
Things you should know
Two things you should know this month
Register devices already on the market in EUDAMED by Friday 27 November.
The Irish regulator, the Health Products Regulatory Authority (HPRA), has restated the deadline. By 28 November 2026, manufacturers must use the UDI/Device module in EUDAMED to register devices placed on the EU market before 28 May 2026, and HPRA says this includes legacy devices sold under certificates from the old directives. 28 November is a Saturday, so plan to finish by Friday 27 November. For the full how-to and the plan for safety summary uploads, see issue 002.
Applies to you if your device, including a legacy device, was on the EU market before 28 May 2026.
- Already selling in the EU. Check that every device placed on the market before 28 May 2026, legacy devices included, is registered by Friday 27 November.
- Still developing. Nothing falls due now. Register as a manufacturer in EUDAMED before you apply to a Notified Body, as step 8 above sets out.
- Regulatory professionals. HPRA's notice names no legal basis for the date, so keep the notice itself on file.
Source: HPRA, "EUDAMED UDI/Device registration deadline", 9 November 2026. Checked 19 November 2026.
Parliament's first vote on the MDR revision is now forecast for 18 January 2027.
The European Parliament's Legislative Observatory now lists 18 January 2027 as the indicative plenary date for the first reading of the revision of the MDR and the IVDR. It shows the file as awaiting a committee decision: the committee responsible has not yet voted.
Update to issue 002. Issue 002 gave 14 December 2026 as the indicative date. The Observatory now shows 18 January 2027.
Source: European Parliament Legislative Observatory, procedure 2025/0404(COD), page dated 19 November 2026. Checked 19 November 2026.
Next step. Get each issue by email: subscribe to Regulatory Matters.
Mistakes on the record: four recent FDA cases
Four FDA cases from November, and the control that catches each
None of the notices below names a regulatory clause as the cause. Each control is general good practice for a company building its first quality system.
Intersurgical Inc.: breathing-tube connectors that could detach. FDA Early Alert, a public notice that a device is being removed, 10 November. The FDA page says some tubes were made with too little bonding solvent to ensure a secure connection, after reports of connectors detaching outside the US. The control: test every bonded joint before release, and record the solvent applied.
Arrow International (Teleflex): a guidewire coating that could detach. FDA Early Alert, 10 November. The FDA page says the coating may swell inconsistently when hydrated with saline and could detach, releasing particles into the bloodstream. The control: test coatings wet, as in use, and repeat the test after any supplier change.
BD Alaris infusion sets in Cardinal Health packs: performance overstated. FDA recall, 9 November. The FDA page reports that BD's own testing found the previously claimed performance of the sets was overestimated and, in some instances, significantly worse. Cardinal Health is updating the instructions for its Presource packs that contain them. The control: tie every performance statement in your instructions to a test report.
Abiomed: heart pump controllers needing hardware, firmware, or software updates. FDA recall, 9 November. The FDA page lists several quality issues, among them a failure to recognise the purge cassette and a sticking, unreliable button that could affect the operator's ability to select menu entries. The control: test every operator control for repeated use, and repeat the test after any design change.
Sources: FDA Early Alert and recall pages for Intersurgical Inc., Arrow International, Cardinal Health, and Abiomed, current as of 9 and 10 November 2026. Checked 19 November 2026.
Next step. Building your first quality system? Company Ready sets up a quality management system sized to your device and your team, with the registers populated and the roles named.
Seven dates to watch before the end of March
What falls due before the end of March
| Date | Market | What falls due, and for whom |
|---|---|---|
| 28 Nov | EU | EUDAMED records due for devices on the market before 28 May 2026. A Saturday: finish by Friday 27 November |
| 30 Nov | US | Comments close on the FDA's proposed guidance lists for fiscal year 2027 |
| Dec | EU | Planned: manufacturers of class III and implantable devices can upload their safety summaries in EUDAMED |
| 31 Dec | CH | swissdamed registration transition ends |
| Jan 2027 | CH | swissdamed fees first invoiced |
| 18 Jan 2027 | EU | Forecast: Parliament's first vote on the MDR and IVDR revision; no committee has voted yet |
| 27 Mar 2027 | EU | MDCG 2026-4 rev.1 asks manufacturers to upload safety summaries for devices on the market before 28 May 2026 as soon as possible, and by 27 March 2027 |
Sources: HPRA, 9 November 2026; FDA, "CDRH Proposed Guidances for Fiscal Year 2027"; MDR Art. 32; MDCG 2026-4 rev.1, October 2026; European Parliament Legislative Observatory, 2025/0404(COD); Swissmedic information sheet BW630_40_001 v2.0. Checked 19 November 2026. CH means Switzerland.
Next step. Get the next dates in your inbox: subscribe to Regulatory Matters.
The question: "Do we need a Notified Body if our device is class I?"
Often no, but not always. A class I manufacturer declares conformity itself, after drawing up the technical documentation in Annexes II and III. A Notified Body takes part only where the device is sterile, has a measuring function, or is a reusable surgical instrument, and then only for those aspects. Software is class I only when none of the other parts of Rule 11 apply. Confirm your class first. See Pathway Ready.
How this issue was compiled. We used primary sources dated 9 to 16 November 2026 and the consolidated text of the MDR, named under each section. Niko Mangold reviewed every regulatory statement before publication. Regulatory Matters is general information and does not replace an assessment of your device.